AMLX

AMYLYX PHARMACEUTICALS, INC.

1 day chart

About AMLX

Amylyx Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in the discovery and development of treatments for neurodegenerative diseases. The Company is focused on the development and commercialization of its product candidate, AMX003 (sodium phenylbutyrate and taurursodiol, also known as ursodoxicoltaurine) for the treatment of amyotrophic lateral sclerosis (ALS). The Company is developing AMX0035 for other neurodegenerative diseases by leveraging knowledge and relationships in the neurodegenerative space. AMX0035 is a dual unfolded protein response (UPR)-Bax apoptosis inhibitor composed of PB and TURSO (also known as TUDCA). Its development of antisense oligonucleotides (ASOs), including lead ASO AMX0114, which targets calpain-2 (CAPN2), a gene encoding calcium-dependent proteolytic enzyme which has been implicated in the pathogenesis of ALS and other neurodegenerative diseases.

Buy US stocks in Australia starting with AMLX. Open an account and start investing today!

Market Capitalisation

$2.04B

Price-earnings ratio

Dividend yield

0.00%

Volume

1.15M

High today

$31.18

Low today

$28.71

Open price

$30.80

52-week high

$41.93

52-week low

$6.51

AMLX FAQs

How much is one share of AMYLYX PHARMACEUTICALS, INC.?

One share of AMYLYX PHARMACEUTICALS, INC. is valued at $29.16.

What is the ticker symbol for AMYLYX PHARMACEUTICALS, INC.?

The ticker symbol for AMYLYX PHARMACEUTICALS, INC. is AMLX.

How do I buy AMLX shares in Australia?

To buy AMLX stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in AMLX

What is the 52-week high for AMYLYX PHARMACEUTICALS, INC. stock?

The AMYLYX PHARMACEUTICALS, INC. 52-week high stock price is $41.93.

What is the 52-week low for AMYLYX PHARMACEUTICALS, INC. stock?

The AMYLYX PHARMACEUTICALS, INC. 52-week low stock price is $6.51.

What is the market capitalisation of AMYLYX PHARMACEUTICALS, INC. AMLX?

As of 29/03/2023 AMYLYX PHARMACEUTICALS, INC. has a market cap of $2B.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.